Effect of pravastatin on erythrocyte membrane fatty acid contents in patients with chronic kidney disease

BACKGROUND: Statin treatment has decreased the risk of cardiovascular events in patients with chronic kidney disease (CKD). Erythrocyte membrane oleic acid level is higher in patients with acute coronary syndrome. This study aimed to evaluate the effect of pravastatin on the erythrocyte membrane fat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Su Mi, Son, Young Ki, Kim, Seong Eun, Kim, Yeong Hoon, Park, Yongsoon, An, Won Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Nephrology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476301/
https://www.ncbi.nlm.nih.gov/pubmed/34078022
http://dx.doi.org/10.23876/j.krcp.20.247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476301/
https://www.ncbi.nlm.nih.gov/pubmed/34078022
http://dx.doi.org/10.23876/j.krcp.20.247

Ejemplares similares